Leptin induces cell proliferation and reduces cell apoptosis by activating c-myc in cervical cancer

Oncology Reports

Volumn 29, Issue 6, 2013, Pages 2291-2296

  Yuan, Yong ^a   Zhang, Juan ^a   Cai, Lin ^a   Ding, Caixia ^a   Wang, Xiaomin ^a   Chen, Hongmei ^a   Wang, Xian ^a   Yan, Jun ^a   Lu, Jianrong ^a  

^a Shaanxi Cancer Hospital   (China)

Author keywords

Apoptosis; bcl 2; c myc; Cervical cancer; Leptin; Proliferation

Indexed keywords

LEPTIN; MYC PROTEIN; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; LEPTIN; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 84876223076     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2390     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. MacDougald OA, Hwang CS, Fan H, Lane MD, et al: Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Natl Acad Sci USA 92: 9034-9037, 1995.
3. Halaas JL, Gajiwala KS, Maffei M, et al: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
4. Huang L and Li C: Leptin: a multifunctional hormone. Cell Res 10: 81-92, 2000.
5. Bouloumié A, Drexler HC, Lafontan M and Busse R: Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83: 1059-1066, 1998. (Pubitemid 28520935)
6. Sierra-Honigmann MR, Nath AK, Murakami C, et al: Biological action of leptin as an angiogenic factor. Science 281: 1683-1686, 1998. (Pubitemid 28435586)
7. Somasunder P, McFadden DW, Hileman SM and Vona-Davis L: Leptin is a growth factor in cancer. J Surg Res 116: 337-349, 2004. (Pubitemid 38175325)
8. Bjorbaek C, Uotani S, da Silva B and Flier JS: Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272: 32686-32695, 1997. (Pubitemid 28011961)
9. Tartaglia LA: The leptin receptor. J Biol Chem 272: 6093-6096, 1997.
10. Saxena NK, Sharma D, Ding X, et al: Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 67: 2497-2507, 2007. (Pubitemid 46548934)
11. Yin N, Wang D, Zhang H, et al: Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res 64: 5870-5875, 2004. (Pubitemid 39095588)
12. Yuan Y, Wang X, Lu J, et al: Effects of leptin on biological behavior of cervical cancer Hela cells and its mechanism. Chin J Clin Exp Pathol 28: 162-165, 2012 (In Chinese).
13. Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213, 2002. (Pubitemid 34969582)
14. Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D and Barrett KE: Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg 94: 346-354, 2007. (Pubitemid 46423854)
15. Ogunwobi OO and Beales IL: The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int J Colorectal Dis 22: 401-409, 2007. (Pubitemid 46336244)
16. Pai R, Lin C, Tran T and Tarnawski A: Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation. Biochem Biophys Res Commun 331: 984-992, 2005. (Pubitemid 40692458)
17. Koda M, Sulkowska M, Wincewicz A, Kanczuga-Koda L, Musiatowicz B, Szymanska M and Sulkowski S: Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer. Ann NY Acad Sci 1095: 90-98, 2007. (Pubitemid 47092441)
18. Choi JH, Park SH, Leung PC and Choi KC: Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J Clin Endocrinol Metab 90: 207-210, 2005. (Pubitemid 40116659)
19. Ishikawa M, Kitayama J and Nagawa H: Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10: 4325-4331, 2004. (Pubitemid 38878870)
20. Hu X, Juneja SC, Maihle NJ and Cleary MP: Leptin - a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94: 1704-1711, 2002. (Pubitemid 35446839)
21. Mauro L, Catalano S, Bossi G, et al: Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res 67: 3412-3421, 2007. (Pubitemid 46724882)
22. Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, Buyse M and Bado A: Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-κB signaling. J Biol Chem 279: 16495-16502, 2004. (Pubitemid 38509348)
23. Escobar-Morreale HF and San Millán JL: Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab 18: 266-272, 2007. (Pubitemid 47332217)
24. Sharma D, Saxena NK, Vertino PM and Anania FA: Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer 13: 629-640, 2006. (Pubitemid 43886682)
25. Sheiness D, Fanshier L and Bishop JM: Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29. J Virol 28: 600-610, 1978.
26. Persson H and Leder P: Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene. Science 225: 718-721, 1984. (Pubitemid 14054316)
27. Vita M and Henriksson M: The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16: 318-330, 2006. (Pubitemid 44311040)
28. O'Connell BC, Cheung AF, Simkevich CP, Tam W, Ren X, Mateyak MK and Sedivy JM: A large scale genetic analysis of c-Myc-regulated gene expression patterns. J Biol Chem 278: 12563-12573, 2003. (Pubitemid 36800246)
29. Nesbit CE, Tersak JM and Prochownik EV: MYC oncogenes and human neoplastic disease. Oncogene 18: 3004-3016, 1999. (Pubitemid 29276540)
30. Chung HJ and Levens D: c-myc expression: keep the noise down! Mol Cells 20: 157-166, 2005.
31. Skirnisdóttir I, Seidal T, Gerdin E and Sorbe B: The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy. Int J Gynecol Cancer 12: 265-276, 2002. (Pubitemid 34787554)
32. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993. (Pubitemid 23259742)
33. Chung TK, Cheung TH, Lo WK, et al: Expression of apoptotic regulators and their significance in cervical cancer. Cancer Lett 180: 63-68, 2002. (Pubitemid 34242965)